EUVIMEDEUVIMED entdecken
Crossref

Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases

Chengting Rong, Hong Zhang, Ling Hu, Yingning Li, Jianjuan Xin, Xinan Wu

Int. Journal of Clinical Pharmacology and Therapeutics · 01.10.2026 · 64 (10) · 537-547

DOI: 10.5414/cp205009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.10.2026. Verfasst von Chengting Rong und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsHumansFemaleRetrospective StudiesRisk FactorsMaleMiddle AgedRisk AssessmentMedical RecordsAgedAdultLogistic ModelsPrediction AlgorithmsROC Curve

Zitieren

APA

Rong, C., Zhang, H., Hu, L., Li, Y., Xin, J., & Wu, X. (2026). Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases. Int. Journal of Clinical Pharmacology and Therapeutics, 64(10), 537-547. https://doi.org/10.5414/cp205009

Vancouver

Rong C, Zhang H, Hu L, Li Y, Xin J, Wu X. Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(10):537-547. doi:10.5414/cp205009

BibTeX
@article{Rong2026,
  author = {Rong, Chengting and Zhang, Hong and Hu, Ling and Li, Yingning and Xin, Jianjuan and Wu, Xinan},
  title = {Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {64},
  number = {10},
  pages = {537--547},
  doi = {10.5414/cp205009}
}
Kostenlos starten →